Published in Women's Health Weekly, November 18th, 2004
This is according to research presented October 26, 2004, by Harry Bartelink, MD, PhD, of The Netherlands Cancer Institute, and his colleagues at the 23rd Meeting of the European Society for Therapeutic Radiology and Oncology.
The analyses were based on data from the EORTC (European Organization for Research and Treatment of Cancer) 22881 trial with updated follow-up (median follow-up: >6 years). For the current study, 5,318 patients with microscopically complete excision of early breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly